CCL11 and urinary bladder cancer: Furthermore, we reveal the involvement of two circulating inflammatory factors in bladder cancer at the same screening criteria (p<0.01), respectively as the level of Eotaxin (CCL11, OR: 1.26, 95% CI 1.06-1.49, p=0.0075) and IL-20 (OR: 1.40, 95% CI 1.09-1.82, p=0.0097) which are all risk factors.